Prevalence of gastric cancer precursor lesions in patients with dyspepsia

Yıl 2010, Cilt: 37 Sayı: 1, 25 - 29, 01.03.2010

Cem Aygün Elif Demirci Mine Çayırcı

https://izlik.org/JA89RF89NJ

Öz

Objectives: In Southeastern cities of Turkey, high preva­lences of Helicobacter pylori infection and gastric cancer are seen. The aim of this study was to evaluate the fre­quency of the precancerous gastric lesions in patients with dyspeptic symptoms who underwent upper gastroin­testinal endoscopy in Adıyaman State Hospital. Materials and methods: We analyzed gastric biopsies taken from corpus and antrum of 234 consecutive pa­tients who underwent upper gastrointestinal endoscopy between January 2009 and May 2009. According to Syd­ney system, chronic gastritis, gastric atrophy, intestinal metaplasia and dysplasia were diagnosed by histological examination. Results: The mean age of patients was 46±15 (16- 82) years. Helicobacter pylori infection was seen in 66.7% of patients. Normal mucosa, chronic gastritis, gastric atro­phy, intestinal metaplasia and dysplasia were diagnosed in 2.7%, 78.6%, 3.4%, 11.5% and 3.8% of gastric biopsy specimens, respectively. Helicobacter pylori infected pa­tients showed a significantly higher prevalence of intes­tinal metaplasia compared with that of the non infected subjects (9.8% vs 1.7% p=0.021). Although prevalence of gastric atrophy and dysplasia were higher among He­licobacter pylori infected patients, the difference did not reached to a statistically significant level (3.0% vs 0.4% p=0.19 and 3.0% vs 0.8% p=0.37 respectively). Conclusion: Our findings suggested that the prevalence of gastric precancerous lesions such as gastric atrophy, intestinal metaplasia, dysplasia and Helicobacter pylori infection were high in dyspeptic patients. This may be re­lated to actual high incidence of gastric cancer in south­eastern region of Turkey.

Anahtar Kelimeler

Dyspepsia , atrophic gastritis , intestinal meta­plasia , dysplasia , Helicobacter pylori.

Dispeptik yakınmalar ile başvuran hastalarda mide kanseri öncü lezyonlarının görülme sıklığı

https://izlik.org/JA89RF89NJ

Öz

Amaç: Türkiye\'nin güneydoğusundaki illerde Helicobac­ter pylori enfeksiyonu ve mide kanseri oldukça sık görül­mektedir. Bu çalışma ile Adıyaman Devlet Hastanesinde dispeptik yakınmalar sebebiyle başvuran hastalarda mide kanseri öncü lezyonlarının görülme sıklığını değerlendir­mek amaçlanmıştır. Gereç ve yöntem: Ocak 2009 ile Mayıs 2009 tarihleri arasında dispeptik yakınmalar nedeni ile başvuran ardışık 234 hasta çalışmaya alınmıştır. Yapılan üst gastrointesti­nal sistem endoskopisi sırasında mide antrum ve korpus­dan biyopsiler alınarak, histopatolojik inceleme (Sydney sınıflaması) ile kronik gastrit, gastrik atrofi, intestinal me­taplazi ve displazi tanıları konulmuştur. Bulgular: İncelenen hastaların yaş ortalaması 46±15 (16-82) yıl idi. Alınan biyopsi örneklerinden, hastaların %66.7\'sinde Helicobacter pylori enfeksiyonu teşhis edildi. Histopatolojik incelemede; normal mukoza %2.7, kronik gastrit %78.6, gastrik atrofi %3.4, intestinal metaplazi %11.5 ve displazi %3.8 oranlarında görüldü. Helicobac­ter pylori enfeksiyonu olan hastalarda intestinal metaplazi görülme sıklığı Helicobacter pylori enfeksiyonu olmayan hastalara göre anlamlı oranlarda yüksekti (sırasıyla, %9.8 ile %1.7, p=0.021). Gastrik atrofi sıklığı (sırasıyla %3.0 ile %0.4 p=0.19) ve displazi sıklığı (sırasıyla, %3.0 ile %0.8 p=0.37) ise Helicobacter pylori enfeksiyonu olan hastalarda olmayanlardan daha yüksek olmakla beraber aradaki fark istatistiksel anlamlı düzeye ulaşmamaktaydı (p>0.05). Sonuç: Mide kanseri öncü lezyonları olan gastrik atrofi, intestinal metaplazi, displazi ile Helicobacter pylori en­feksiyonu dispeptik yakınmalar ile başvuran hastalarda sıklıkla görülmektedir. Bu durum Türkiye\'nin güneydoğu­sunda yüksek insidansda görülen mide kanseri ile ilgili olabilir.

Anahtar Kelimeler

Dispepsi , atrofik gastrit , intestinal metaplazi , displazi , Helicobacter pylori.

Kaynakça

• Correa P. Human gastric carcinogenesis: A multistep and multifactorial process- the first American Cancer Society award lecture on cancer epidemiology and prevention. Can- cer Res 1992;52: 635-674.
• Kato I, Tomigana S, Ito Y, et al. A prospective study of atro- phic gastritis and stomach cancer risk. Jpn J Cancer Res 1992; 83:1137-1142.
• Tatsuta M, Iishi H, Nazaizumi A et al. Fundal atrophic gas- tritis as a risk factor for gastric cancer. Int J Cancer 1993; 53: 70-74.
• You W, Chang Y. Epidemiology of precancerous gastric le- sions. J Gastroenterol Hepatol 1993; 8: 375-382.
• Filipe M, Jass M . İntestinal metaplasia subtypes and cancer risk. In Filipe M, Jass J (eds): Gastric Carcinomas. Edin- burgh, Churchill Livingstone, 1986, p87.
• Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32: 1110-1113.
• Kokkola A, Haapiainen R, Laxen F, et al. Risk of gastric car- cinoma in patients with mucosal dysplasia associated with atrophic gastritis: A follow-up study. J Clin Pathol 1996; 49: 979-984.
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. In- ternational Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181.
• Türkdogan MK, Akman N, Tuncer I, et al. Epidemiolgical aspects of endemic upper gastrointestinal cancers in eastern Turkey. Hepatogastroenterology 2005; 52: 496-500.
• Bor S, Vardar R, Ormeci N, et al. Prevalence patterns of Gastric cancers in Turkey: Model of a developing country with high occurence of Helicobacter pylori. J Gastroenterol Hepatol 2007; 22: 2242-2245.
• Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001; 15: 983-998.
• Özden A, Bozdayı G, Özkan M, Köse KS. Changes in the seroepidemiological pattern of Helicobacter pylori infec- tion over the last 10 years in Turkey. Turk J Gastroenterol 2004; 15: 156-158.
• Saruç M, Ozden N, Turkel N, et al. Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey. Brazilian J Med Biol Res 2003; 36: 747-751.
• Sari YS, Sander E, Erkan E, Tunali V. Endoscopic diagno- ses and CLO test results in 9239 cases, prevalence of Heli- cobacter pylori in Istanbul, Turkey. J Gastroenterol Hepatol 2007; 22: 1706-11.
• Tsujii M, Kawano S, Tsuji S, et al. Ammonia: a possible promoter in Helicobacter pylori-related gastric carcinogen- esis. Cancer Lett 1992; 65: 15-18.
• Tsujii M, Kawano S, Tsuji S, et al. Mechanism for ammo- nia-induced promotion of gastric carcinogenesis in rats. Carcinogenesis 1995;16:563-566.
• Davies GR, Banatvala N, Collins CE, et al. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994;29:419-424.
• Kimura K. Chronological transition of the fundic-pyloric boder determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63:584-592.
• Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastri- tis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993;34:1032-1037.